In line with these previous studies, our results in the PyMT mouse model show that anti-CD115 mAb potentiates the effect of Paclitaxel for inhibiting tumor growth and prolonging survival, providing another piece of evidence that targeting TAMs will ameliorate the efficacy of chemotherapeutic treatments. This evidence concerns the gene CSF1R and neoplasm.